FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:166-178 January 12, 2006 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Almost 4000 cases of acute lymphoblastic leukemia (ALL) are diagnosed annually in the United States, approximately two thirds of which are in children and adolescents, making ALL the most common cancer in these age groups.¹ Optimal use of the same antileukemic agents that were developed from the 1950s through the 1980s, together with a stringent application of prognostic factors for risk-directed therapy in clinical trials, has resulted in a steady improvement in treatment outcome.¹ In the 1990s, the five-year event-free survival rates for childhood ALL generally ranged from 70 to 83 percent in developed countries (Table 1),^{2,3,4,5,6,7,8,9,10,11} with . . . [Full Text of this Article]

Risk Assessment

Factors Predicting Clinical Outcome

Treatment Regimen

Clinical Features

Genetics of Leukemia Cells

Host Pharmacodynamics and Pharmacogenetics

Global Gene-Expression Patterns

Early Response to Treatment

Factors Predicting Treatment-Related Toxic Effects

Treatment

Remission Induction

Intensification (Consolidation) Therapy

Allogeneic Hematopoietic Stem-Cell Transplantation

Continuation Treatment

Treatment Directed to the Central Nervous System

Future Directions

Source Information

From the Departments of Hematology and Oncology (C.-H.P.), Pharmaceutical Sciences (W.E.E.), and Pathology (C.-H.P.), St. Jude Children's Research Hospital; and the Colleges of Medicine (C.-H.P., W.E.E.) and Pharmacy (W.E.E.), University of Tennessee Health Science Center — both in Memphis.

Address reprint requests to Dr. Pui at St. Jude Children's Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105-2794, or at ching-hon.pui@stjude.org.

This article has been cited by other articles:

• Marston, E., Weston, V., Jesson, J., Maina, E., McConville, C., Agathanggelou, A., Skowronska, A., Mapp, K., Sameith, K., Powell, J. E., Lawson, S., Kearns, P., Falciani, F., Taylor, M., Stankovic, T. (2009). Stratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical response. Blood 113: 117-126 [Abstract] [Full Text]  
• Pottier, N., Yang, W., Assem, M., Panetta, J. C., Pei, D., Paugh, S. W., Cheng, C., Den Boer, M. L., Relling, M. V., Pieters, R., Evans, W. E., Cheok, M. H. (2008). The SWI/SNF Chromatin-Remodeling Complex and Glucocorticoid Resistance in Acute Lymphoblastic Leukemia. JNCI J Natl Cancer Inst 100: 1792-1803 [Abstract] [Full Text]  
• Inthal, A., Krapf, G., Beck, D., Joas, R., Kauer, M. O., Orel, L., Fuka, G., Mann, G., Panzer-Grumayer, E. R. (2008). Role of the Erythropoietin Receptor in ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia. Clin. Cancer Res. 14: 7196-7204 [Abstract] [Full Text]  
• Yang, J. J., Bhojwani, D., Yang, W., Cai, X., Stocco, G., Crews, K., Wang, J., Morrison, D., Devidas, M., Hunger, S. P., Willman, C. L., Raetz, E. A., Pui, C.-h., Evans, W. E., Relling, M. V., Carroll, W. L. (2008). Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood 112: 4178-4183 [Abstract] [Full Text]  
• Barlogie, B., Pineda-Roman, M., van Rhee, F., Haessler, J., Anaissie, E., Hollmig, K., Alsayed, Y., Waheed, S., Petty, N., Epstein, J., Shaughnessy, J. D. Jr, Tricot, G., Zangari, M., Zeldis, J., Barer, S., Crowley, J. (2008). Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities. Blood 112: 3115-3121 [Abstract] [Full Text]  
• Lo, B., Kriegstein, A., Grady, D. (2008). Clinical trials in stem cell transplantation: guidelines for scientific and ethical review. Clin Trials 5: 517-522 [Abstract]  
• Ogawa, A., Firth, A. L., Yao, W., Rubin, L. J., Yuan, J. X.-J. (2008). Prednisolone inhibits PDGF-induced nuclear translocation of NF-{kappa}B in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L648-L657 [Abstract] [Full Text]  
• Bhojwani, D., Kang, H., Menezes, R. X., Yang, W., Sather, H., Moskowitz, N. P., Min, D.-J., Potter, J. W., Harvey, R., Hunger, S. P., Seibel, N., Raetz, E. A., Pieters, R., Horstmann, M. A., Relling, M. V., den Boer, M. L., Willman, C. L., Carroll, W. L. (2008). Gene Expression Signatures Predictive of Early Response and Outcome in High-Risk Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. JCO 26: 4376-4384 [Abstract] [Full Text]  
• Kawamata, N., Ogawa, S., Zimmermann, M., Niebuhr, B., Stocking, C., Sanada, M., Hemminki, K., Yamatomo, G., Nannya, Y., Koehler, R., Flohr, T., Miller, C. W., Harbott, J., Ludwig, W.-D., Stanulla, M., Schrappe, M., Bartram, C. R., Koeffler, H. P. (2008). Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Proc. Natl. Acad. Sci. USA 105: 11921-11926 [Abstract] [Full Text]  
• Tucci, F., Arico, M. (2008). Treatment of pediatric acute lymphoblastic leukemia. haematol 93: 1124-1128 [Full Text]  
• Jansen, N. C.A.J., Kingma, A., Schuitema, A., Bouma, A., Veerman, A. J.P., Kamps, W. A. (2008). Neuropsychological Outcome in Chemotherapy-Only-Treated Children With Acute Lymphoblastic Leukemia. JCO 26: 3025-3030 [Abstract] [Full Text]  
• Rubnitz, J. E., Wichlan, D., Devidas, M., Shuster, J., Linda, S. B., Kurtzberg, J., Bell, B., Hunger, S. P., Chauvenet, A., Pui, C.-H., Camitta, B., Pullen, J. (2008). Prospective Analysis of TEL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. JCO 26: 2186-2191 [Abstract] [Full Text]  
• Zhu, N., Gu, L., Li, F., Zhou, M. (2008). Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells. Molecular Cancer Therapeutics 7: 1101-1109 [Abstract] [Full Text]  
• Nienhuis, A. W. (2008). Development of gene therapy for blood disorders. Blood 111: 4431-4444 [Abstract] [Full Text]  
• Davis, M. C., McColl, K. S., Zhong, F., Wang, Z., Malone, M. H., Distelhorst, C. W. (2008). Dexamethasone-induced Inositol 1,4,5-Trisphosphate Receptor Elevation in Murine Lymphoma Cells Is Not Required for Dexamethasone-mediated Calcium Elevation and Apoptosis. J. Biol. Chem. 283: 10357-10365 [Abstract] [Full Text]  
• Flex, E., Petrangeli, V., Stella, L., Chiaretti, S., Hornakova, T., Knoops, L., Ariola, C., Fodale, V., Clappier, E., Paoloni, F., Martinelli, S., Fragale, A., Sanchez, M., Tavolaro, S., Messina, M., Cazzaniga, G., Camera, A., Pizzolo, G., Tornesello, A., Vignetti, M., Battistini, A., Cave, H., Gelb, B. D., Renauld, J.-C., Biondi, A., Constantinescu, S. N., Foa, R., Tartaglia, M. (2008). Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. JEM 205: 751-758 [Abstract] [Full Text]  
• Ribera, J.-M., Oriol, A., Sanz, M.-A., Tormo, M., Fernandez-Abellan, P., del Potro, E., Abella, E., Bueno, J., Parody, R., Bastida, P., Grande, C., Heras, I., Bethencourt, C., Feliu, E., Ortega, J.-J. (2008). Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Espanol de Tratamiento en Hematologia Pediatric-Based Protocol ALL-96. JCO 26: 1843-1849 [Abstract] [Full Text]  
• De Keersmaecker, K., Lahortiga, I., Mentens, N., Folens, C., Van Neste, L., Bekaert, S., Vandenberghe, P., Odero, M. D., Marynen, P., Cools, J. (2008). In vitro validation of {gamma}-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. haematol 93: 533-542 [Abstract] [Full Text]  
• Moorman, A. V. (2008). One man's dose, another man's poison. Blood 111: 3303-3304 [Full Text]  
• Marchese, V. G, Connolly, B. H, Able, C., Booten, A. R, Bowen, P., Porter, B. M, Rai, S. N, Hancock, M. L, Pui, C.-H., Howard, S., Neel, M. D, Kaste, S. C (2008). Relationships Among Severity of Osteonecrosis, Pain, Range of Motion, and Functional Mobility in Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia. ptjournal 88: 341-350 [Abstract] [Full Text]  
• Goldstone, A. H., Richards, S. M., Lazarus, H. M., Tallman, M. S., Buck, G., Fielding, A. K., Burnett, A. K., Chopra, R., Wiernik, P. H., Foroni, L., Paietta, E., Litzow, M. R., Marks, D. I., Durrant, J., McMillan, A., Franklin, I. M., Luger, S., Ciobanu, N., Rowe, J. M. (2008). In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 111: 1827-1833 [Abstract] [Full Text]  
• Mohty, M., Labopin, M., Tabrizzi, R., Theorin, N., Fauser, A. A, Rambaldi, A., Maertens, J., Slavin, S., Majolino, I., Nagler, A., Blaise, D., Rocha, V., on behalf of the Acute Leukemia Working Party, (2008). Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. haematol 93: 303-306 [Abstract] [Full Text]  
• Bunpo, P., Murray, B., Cundiff, J., Brizius, E., Aldrich, C. J., Anthony, T. G. (2008). Alanyl-Glutamine Consumption Modifies the Suppressive Effect of L-Asparaginase on Lymphocyte Populations in Mice. J. Nutr. 138: 338-343 [Abstract] [Full Text]  
• Kawamata, N., Ogawa, S., Zimmermann, M., Kato, M., Sanada, M., Hemminki, K., Yamatomo, G., Nannya, Y., Koehler, R., Flohr, T., Miller, C. W., Harbott, J., Ludwig, W.-D., Stanulla, M., Schrappe, M., Bartram, C. R., Koeffler, H. P. (2008). Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 111: 776-784 [Abstract] [Full Text]  
• Inaba, H., Khan, R. B., Laningham, F. H., Crews, K. R., Pui, C.-H., Daw, N. C. (2008). Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 19: 178-184 [Abstract] [Full Text]  
• Seibel, N. L. (2008). Treatment of Acute Lymphoblastic Leukemia in Children and Adolescents: Peaks and Pitfalls. ASH Education Book 2008: 374-380 [Abstract] [Full Text]  
• Fielding, A. (2008). The Treatment of Adults with Acute Lymphoblastic Leukemia. ASH Education Book 2008: 381-389 [Abstract] [Full Text]  
• Relling, M. V., Evans, W. E., Pui, C.-H. (2008). Continue to study childhood ALL. Blood 111: 468-469 [Full Text]  
• Mi, S., Lu, J., Sun, M., Li, Z., Zhang, H., Neilly, M. B., Wang, Y., Qian, Z., Jin, J., Zhang, Y., Bohlander, S. K., Le Beau, M. M., Larson, R. A., Golub, T. R., Rowley, J. D., Chen, J. (2007). MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 104: 19971-19976 [Abstract] [Full Text]  
• Cario, G., Izraeli, S., Teichert, A., Rhein, P., Skokowa, J., Moricke, A., Zimmermann, M., Schrauder, A., Karawajew, L., Ludwig, W.-D., Welte, K., Schunemann, H. J., Schlegelberger, B., Schrappe, M., Stanulla, M. (2007). High Interleukin-15 Expression Characterizes Childhood Acute Lymphoblastic Leukemia With Involvement of the CNS. JCO 25: 4813-4820 [Abstract] [Full Text]  
• Fischer, S., Mann, G., Konrad, M., Metzler, M., Ebetsberger, G., Jones, N., Nadel, B., Bodamer, O., Haas, O. A., Schmitt, K., Panzer-Grumayer, E. R. (2007). Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin. Blood 110: 3036-3038 [Abstract] [Full Text]  
• Pottier, N., Cheok, M. H., Yang, W., Assem, M., Tracey, L., Obenauer, J. C., Panetta, J. C., Relling, M. V., Evans, W. E. (2007). Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter snp that alters PARP1 binding and SMARCB1 expression. Hum Mol Genet 16: 2261-2271 [Abstract] [Full Text]  
• Eiser, C. (2007). Beyond Survival: Quality of Life and Follow-up After Childhood Cancer. J Pediatr Psychol 32: 1140-1150 [Abstract] [Full Text]  
• Rowe, J. M., Goldstone, A. H. (2007). How I treat acute lymphocytic leukemia in adults. Blood 110: 2268-2275 [Abstract] [Full Text]  
• Kang, M. H., Kang, Y. H., Szymanska, B., Wilczynska-Kalak, U., Sheard, M. A., Harned, T. M., Lock, R. B., Reynolds, C. P. (2007). Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. Blood 110: 2057-2066 [Abstract] [Full Text]  
• Chauvenet, A. R., Martin, P. L., Devidas, M., Linda, S. B., Bell, B. A., Kurtzberg, J., Pullen, J., Pettenati, M. J., Carroll, A. J., Shuster, J. J., Camitta, B. (2007). Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood 110: 1105-1111 [Abstract] [Full Text]  
• Flotho, C., Coustan-Smith, E., Pei, D., Cheng, C., Song, G., Pui, C.-H., Downing, J. R., Campana, D. (2007). A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 110: 1271-1277 [Abstract] [Full Text]  
• Harila-Saari, A. H., Lahteenmaki, P. M., Pukkala, E., Kyyronen, P., Lanning, M., Sankila, R. (2007). Scholastic Achievements of Childhood Leukemia Patients: A Nationwide, Register-Based Study. JCO 25: 3518-3524 [Abstract] [Full Text]  
• Florin, T. A., Fryer, G. E., Miyoshi, T., Weitzman, M., Mertens, A. C., Hudson, M. M., Sklar, C. A., Emmons, K., Hinkle, A., Whitton, J., Stovall, M., Robison, L. L., Oeffinger, K. C. (2007). Physical Inactivity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol. Biomarkers Prev. 16: 1356-1363 [Abstract] [Full Text]  
• Maule, M., Scelo, G., Pastore, G., Brennan, P., Hemminki, K., Tracey, E., Sankila, R., Weiderpass, E., Olsen, J. H., McBride, M. L., Brewster, D. H., Pompe-Kirn, V., Kliewer, E. V., Chia, K. S., Tonita, J. M., Martos, C., Jonasson, J. G., Merletti, F., Boffetta, P. (2007). Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma: An International Study. JNCI J Natl Cancer Inst 99: 790-800 [Abstract] [Full Text]  
• Karimova, E. J., Rai, S. N., Howard, S. C., Neel, M., Britton, L., Pui, C.-H., Kaste, S. C. (2007). Femoral Head Osteonecrosis in Pediatric and Young Adult Patients With Leukemia or Lymphoma. JCO 25: 1525-1531 [Abstract] [Full Text]  
• Moorman, A. V., Harrison, C. J., Buck, G. A. N., Richards, S. M., Secker-Walker, L. M., Martineau, M., Vance, G. H., Cherry, A. M., Higgins, R. R., Fielding, A. K., Foroni, L., Paietta, E., Tallman, M. S., Litzow, M. R., Wiernik, P. H., Rowe, J. M., Goldstone, A. H., Dewald, G. W., on behalf of the Medical Research Council (MRC)/Na, (2007). Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109: 3189-3197 [Abstract] [Full Text]  
• Juric, D., Lacayo, N. J., Ramsey, M. C., Racevskis, J., Wiernik, P. H., Rowe, J. M., Goldstone, A. H., O'Dwyer, P. J., Paietta, E., Sikic, B. I. (2007). Differential Gene Expression Patterns and Interaction Networks in BCR-ABL-Positive and -Negative Adult Acute Lymphoblastic Leukemias. JCO 25: 1341-1349 [Abstract] [Full Text]  
• Douer, D., Yampolsky, H., Cohen, L. J., Watkins, K., Levine, A. M., Periclou, A. P., Avramis, V. I. (2007). Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. Blood 109: 2744-2750 [Abstract] [Full Text]  
• Hijiya, N., Hudson, M. M., Lensing, S., Zacher, M., Onciu, M., Behm, F. G., Razzouk, B. I., Ribeiro, R. C., Rubnitz, J. E., Sandlund, J. T., Rivera, G. K., Evans, W. E., Relling, M. V., Pui, C.-H. (2007). Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia. JAMA 297: 1207-1215 [Abstract] [Full Text]  
• Aragon-Ching, J. B., Zujewski, J. A. (2007). CNS Metastasis: An Old Problem in a New Guise. Clin. Cancer Res. 13: 1644-1647 [Abstract] [Full Text]  
• Chattopadhyay, S., Moran, R. G., Goldman, I. D. (2007). Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications. Molecular Cancer Therapeutics 6: 404-417 [Abstract] [Full Text]  
• Fielding, A. K., Richards, S. M., Chopra, R., Lazarus, H. M., Litzow, M. R., Buck, G., Durrant, I. J., Luger, S. M., Marks, D. I., Franklin, I. M., McMillan, A. K., Tallman, M. S., Rowe, J. M., Goldstone, A. H., Medical Research Council of the United Kingdom Adu, (2007). Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood 109: 944-950 [Abstract] [Full Text]  
• Ge, Y., Haska, C. L., LaFiura, K., Devidas, M., Linda, S. B., Liu, M., Thomas, R., Taub, J. W., Matherly, L. H. (2007). Prognostic Role of the Reduced Folate Carrier, the Major Membrane Transporter for Methotrexate, in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group. Clin. Cancer Res. 13: 451-457 [Abstract] [Full Text]  
• Tedeschi, R., Bloigu, A., Ogmundsdottir, H. M., Marus, A., Dillner, J., dePaoli, P., Gudnadottir, M., Koskela, P., Pukkala, E., Lehtinen, T., Lehtinen, M. (2007). Activation of Maternal Epstein-Barr Virus Infection and Risk of Acute Leukemia in the Offspring. Am J Epidemiol 165: 134-137 [Abstract] [Full Text]  
• Choi, J., Hwang, Y. K., Sung, K. W., Lee, S. H., Yoo, K. H., Jung, H. L., Koo, H. H., Kim, H.-J., Kang, H. J., Shin, H. Y., Ahn, H. S. (2007). Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 109: 471-477 [Abstract] [Full Text]  
• Ribera, J.-M., Ortega, J.-J., Oriol, A., Bastida, P., Calvo, C., Perez-Hurtado, J.-M., Gonzalez-Valentin, M.-E., Martin-Reina, V., Molines, A., Ortega-Rivas, F., Moreno, M.-J., Rivas, C., Egurbide, I., Heras, I., Poderos, C., Martinez-Revuelta, E., Guinea, J.-M., del Potro, E., Deben, G. (2007). Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial. JCO 25: 16-24 [Abstract] [Full Text]  
• Stock, W., Seibel, N. L. (2007). Acute lymphoblastic leukemia and lymphoblastic lymphoma. ASH-SAP 2007: 253-264 [Full Text]  
• Burmeister, T., Gokbuget, N., Reinhardt, R., Rieder, H., Hoelzer, D., Schwartz, S. (2006). NUP214-ABL1 in adult T-ALL: the GMALL study group experience. Blood 108: 3556-3559 [Abstract] [Full Text]  
• Reinert, R. B., Oberle, L. M., Wek, S. A., Bunpo, P., Wang, X. P., Mileva, I., Goodwin, L. O., Aldrich, C. J., Durden, D. L., McNurlan, M. A., Wek, R. C., Anthony, T. G. (2006). Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase. J. Biol. Chem. 281: 31222-31233 [Abstract] [Full Text]  
• Smyth, R. L. (2006). Researching childhood illness: the need for methodological studies. Chronic Illness 2: 183-184  
• Pui, C.-H. (2006). Two tales of infant leukemia. Blood 107: 4576-4577 [Full Text]  
• Gokbuget, N., Hoelzer, D. (2006). Treatment of Adult Acute Lymphoblastic Leukemia. ASH Education Book 2006: 133-141 [Abstract] [Full Text]  
• Pui, C.-H. (2006). Central Nervous System Disease in Acute Lymphoblastic Leukemia: Prophylaxis and Treatment. ASH Education Book 2006: 142-146 [Abstract] [Full Text]